Skip to content

The effects of glucose administration on the improvement of infantile colic

A clinical trial study for comparison the effects of glucose and Simeticone administration on reducing crying times in newborns with infantile colic

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017092636423N1
Enrollment
76
Registered
2017-10-28
Start date
2017-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Infantile colic. Other and unspecified abdominal pain

Interventions

Intervention 1: Control group: Simethicone (2.5 mg/kg per day) is administrated for 28 days. Intervention 2: Intervention group: Oral glucose is administrated as 25% or 30% solution (2.5 mg/kg per day
Treatment - Drugs
Control group: Simethicone (2.5 mg/kg per day) is administrated for 28 days.
Intervention group: Oral glucose is administrated as 25% or 30% solution (2.5 mg/kg per day) for 28 days.

Sponsors

Research Deputy of Zabol University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
21 Days to 6 Months

Inclusion criteria

Inclusion criteria: Inclusion criteria: Diagnosis of infantile colic (IC) based on the Wessel criteria; the age of 3 weeks to 6 months Exclusion criteria: Neonates with systemic disorders; history of taking medications for IC

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Reduction in crying times. Timepoint: One week before the initiation of the intervention, and at the end of the intervention. Method of measurement: Questionnaire filled by mothers.

Secondary

MeasureTime frame
Improvement of general conditions of the neonates as perceived by mothers. Timepoint: One week before initiation of the intervention, and at the end of intervention. Method of measurement: Questionnaire filled by mothers.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Bazi

Zabol University of Medical Sciences

m.baziali@gmail.com+98 543220770

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026